Past investments

• Santaris Pharma
• AM Pharma
• Pathway Medical Technologies
• Impella Cardiosystems
• Borean Pharma
• Roche Glycart
• NovoGI
• Oxyrane UK
• OMEICOS Therapeutics
• Inflazome
• Amakem
• Pulmologix
• Ardana Bioscience
• CoviCept Therapeutics
• Rigontec
• FlowMedica
• Oxular
• NeRRe Therapeutics
• Hookipa Pharma
• NorthSea Therapeutics
• SANIFIT
• PneumRx
• Gotham Therapeutics
• Catalym
• Insmed
• Mitralign
• Prilenia
• KaNDy Therapeutics
• Ario Pharma
• Cardoz
• CircuLite
• BioVex
• Cytheris
• Bluebird Bio
• Pieris AG
• UniQure
• CellNovo
• Akarna Therapeutics
• Escalier Biosciences
• Azafaros
• Enterprise Therapeutics
• Bioceros
• Replimune Group
• Exosome Diagnostics
• Acorda Therapeutics
• Dyne Therapeutics
• gIcare Pharma
• Amphista Therapeutics
• Milestone Pharmaceuticals
• Dezima Pharma
• Fovea Pharmaceuticals
• Inversago Pharma
• Gyroscope Therapeutics
• New Amsterdam Pharma
• Autonomic Technologies
• Xention
• Achilles Therapeutics
• arGEN-X
• Curetis
• ACADIA Pharmaceuticals
• Allecra Therapeutics
• PanGenetics
• Promedior
• Transave
• Argos Therapeutics
• enGene
• Prexton Therapeutics